216 related articles for article (PubMed ID: 19576231)
1. Opioid receptor and NO/cGMP pathway as a mechanism of peripheral antinociceptive action of the cannabinoid receptor agonist anandamide.
Reis GM; Pacheco D; Perez AC; Klein A; Ramos MA; Duarte ID
Life Sci; 2009 Aug; 85(9-10):351-6. PubMed ID: 19576231
[TBL] [Abstract][Full Text] [Related]
2. Endogenous cannabinoid receptor agonist anandamide induces peripheral antinociception by activation of ATP-sensitive K+ channels.
Reis GM; Ramos MA; Pacheco Dda F; Klein A; Perez AC; Duarte ID
Life Sci; 2011 Apr; 88(15-16):653-7. PubMed ID: 21277864
[TBL] [Abstract][Full Text] [Related]
3. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
Romero TR; Resende LC; Guzzo LS; Duarte ID
Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
[TBL] [Abstract][Full Text] [Related]
4. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Romero TR; Pacheco Dda F; Duarte ID
Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
[TBL] [Abstract][Full Text] [Related]
5. alpha(2)-Adrenoceptor agonist xylazine induces peripheral antinociceptive effect by activation of the L-arginine/nitric oxide/cyclic GMP pathway in rat.
Romero TR; Duarte ID
Eur J Pharmacol; 2009 Jun; 613(1-3):64-7. PubMed ID: 19389395
[TBL] [Abstract][Full Text] [Related]
6. delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway.
Pacheco DF; Reis GM; Francischi JN; Castro MS; Perez AC; Duarte ID
Life Sci; 2005 Nov; 78(1):54-60. PubMed ID: 16135369
[TBL] [Abstract][Full Text] [Related]
7. The kappa-opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the L-arginine/nitric oxide/cyclic GMP pathway.
Amarante LH; Duarte ID
Eur J Pharmacol; 2002 Nov; 454(1):19-23. PubMed ID: 12409000
[TBL] [Abstract][Full Text] [Related]
8. Curcumin induces peripheral antinociception by opioidergic and cannabinoidergic mechanism: Pharmacological evidence.
Aguiar DD; Gonzaga ACR; Teófilo ALH; Miranda FA; Perez AC; Duarte IDG; Romero TRL
Life Sci; 2022 Mar; 293():120279. PubMed ID: 35032552
[TBL] [Abstract][Full Text] [Related]
9. The Involvement of the Endocannabinoid System in the Peripheral Antinociceptive Action of Ketamine.
Ferreira RCM; Castor MGM; Piscitelli F; Di Marzo V; Duarte IDG; Romero TRL
J Pain; 2018 May; 19(5):487-495. PubMed ID: 29247851
[TBL] [Abstract][Full Text] [Related]
10. Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats.
Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Côrtes SF; Duarte ID
Anesth Analg; 2011 Nov; 113(5):1254-9. PubMed ID: 21788321
[TBL] [Abstract][Full Text] [Related]
11. NO/cGMP production is important for the endogenous peripheral control of hyperalgesia during inflammation.
Alves DP; da Motta PG; Romero TR; Klein A; Duarte ID
Nitric Oxide; 2013 Jan; 28():8-13. PubMed ID: 22995857
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide and potassium channels but not opioid and cannabinoid receptors mediate tramadol-induced peripheral antinociception in rat model of paw pressure withdrawal.
Soares-Santos RR; Machado DP; Romero TL; Duarte IDG
Can J Physiol Pharmacol; 2024 Mar; 102(3):218-227. PubMed ID: 37976474
[TBL] [Abstract][Full Text] [Related]
13. Additive antinociceptive effect of the combination of diazoxide, an activator of ATP-sensitive K+ channels, and sodium nitroprusside and dibutyryl-cGMP.
Alves DP; Soares AC; Francischi JN; Castro MS; Perez AC; Duarte ID
Eur J Pharmacol; 2004 Apr; 489(1-2):59-65. PubMed ID: 15063156
[TBL] [Abstract][Full Text] [Related]
14. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to cannabinoid receptors activation in mice.
Veloso CC; Ferreira RCM; Rodrigues VG; Duarte LP; Klein A; Duarte ID; Romero TRL; Perez AC
Inflammopharmacology; 2018 Feb; 26(1):227-233. PubMed ID: 28889355
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive activity of petroleum ether fraction obtained from methanolic extract of Clinacanthus nutans leaves involves the activation of opioid receptors and NO-mediated/cGMP-independent pathway.
Zakaria ZA; Abdul Rahim MH; Mohd Sani MH; Omar MH; Ching SM; Abdul Kadir A; Ahmed QU
BMC Complement Altern Med; 2019 Apr; 19(1):79. PubMed ID: 30940120
[TBL] [Abstract][Full Text] [Related]
16. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181
[TBL] [Abstract][Full Text] [Related]
17. N-(4-Methoxy-2-nitrophenyl)hexadecanamide, a palmitoylethanolamide analogue, reduces formalin-induced nociception.
Roa-Coria JE; Navarrete-Vázquez G; Fowler CJ; Flores-Murrieta FJ; Déciga-Campos M; Granados-Soto V
Life Sci; 2012 Dec; 91(25-26):1288-94. PubMed ID: 23069585
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in peripheral antinociception induced by N-palmitoyl-ethanolamine in rats.
Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Cortes SF; Duarte ID
J Neurosci Res; 2012 Jul; 90(7):1474-9. PubMed ID: 22411529
[TBL] [Abstract][Full Text] [Related]
19. Role of the NO-cGMP-K
Ortiz MI; Cariño-Cortés R; Muñoz-Pérez VM; Salas-Casas A; Castañeda-Hernández G
Can J Physiol Pharmacol; 2021 Oct; 99(10):1048-1056. PubMed ID: 33857384
[TBL] [Abstract][Full Text] [Related]
20. L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway.
Duarte ID; Ferreira SH
Mediators Inflamm; 2000; 9(1):25-30. PubMed ID: 10877451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
